[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2024 Global Respiratory Disease Testing Market--US, Europe, Japan--Shares and Segment Forecasts--Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis

August 2024 | | ID: 20E0525D98CEEN
Venture Planning Group

US$ 9,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from LeadingMarketResearch.com provides analysis of the global respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.
The report is available by section, and can be customized to specific information needs and budget.
About this Report
This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
Current scientific views on epidemiology and etiology are presented for:
Adenovirus
Coronavirus
Enterovirus
Influenza
Legionella
Mononucleosis
Mycoplasma
Pneumonia
RSV
Rhinovirus
Tuberculosis
The report provides test volume and sales forecasts by country and market segment, including:
Hospitals
Commercial/Private Labs
Physician Offices
Public Health Labs
In addition to test volume and sales projections, the report presents market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report
Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.
Reviews features and operating characteristics of major analyzers used for respiratory disease testing;
Profiles key suppliers and potential market entrants developing innovative technologies and products
Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted.


More Publications